PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

PTC Therapeutics (PTCT) Misses Q4 EPS by 39c

February 22, 2022 4:04 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($2.03), $0.39 worse than the analyst estimate of ($1.64). Revenue for the quarter came in at $165.2 million versus the consensus estimate of $150.83 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

... More